HumeCare+ vs Maximus: Protocol and Price Compared
HumeCare+ vs Maximus: quick verdict first. HumeCare+ emphasizes a bundled GLP-1 protocol with muscle support, monthly body composition scans, and a 10% or your money back promise; Maximus is a lower cost telemedicine option offering compounded semaglutide for $132.99/month through licensed doctors and U.S. pharmacies. HumeCare+ is best for people who want medication plus structured supportive therapies. Maximus is best for cost conscious patients who want straightforward telemedicine access.
Explore HumeCare+ protocol and features
How these providers differ at a glance
Compare HumeCare+ and Maximus across price, medication options, added supportive ingredients, monitoring, clinician access, and outcome guarantees. The primary keyword HumeCare+ vs Maximus appears here to guide searches and the comparison below.
Most distinctive differences
- Price and product mix: HumeCare+ lists semaglutide from $199/month and tirzepatide protocols from $299/month; Maximus lists semaglutide at $132.99/month.
- Supportive protocol vs no-frills medication: HumeCare+ bundles glycine, B12 and B6 into its compounded formulation and includes a dedicated app; Maximus offers a low flat rate for semaglutide via telemedicine with prescriptions approved by licensed doctors.
- Monitoring: HumeCare+ provides monthly body composition scans to track lean mass versus fat; Maximus emphasizes telemedicine convenience and domestic pharmacy fulfillment but does not publish body composition tracking.
- Guarantee and claims: HumeCare+ advertises a 10% or your money back promise over six months with eligibility terms; Maximus does not publish a weight loss guarantee.
Side by side comparison table
| Criteria | HumeCare+ | Maximus |
|---|---|---|
| Starting price | Semaglutide from $199/mo; tirzepatide protocol $299/mo | $132.99/month |
| Medication options | Compounded semaglutide or tirzepatide with provider-set dosing | Compounded semaglutide prescribed by licensed doctors |
| Supportive ingredients | Glycine plus vitamins B6 and B12 built into formulation | No supportive ingredients listed |
| Monitoring | Monthly body composition scans to track lean mass vs fat | Telemedicine only; no published body composition tracking |
| Clinician access | Unlimited clinician access and a U.S. care team available 24/7 | Prescriptions approved by licensed doctors via telemedicine |
| Outcome guarantee | 10% or your money back promise over six months. See full terms | No published weight loss guarantee |
| Shipping and cancellation | Free next-day delivery, cancel subscription anytime | Free expedited shipping; direct-pay model with no insurance billing |
| Regulatory note | Compounded medications are not FDA-evaluated for safety, quality, or efficacy | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Price and value: which is more economical?
Maximus lists a lower flat rate at $132.99/month for compounded semaglutide making it the more affordable direct-pay option in this comparison. HumeCare+ starts at $199/month for semaglutide and $299/month for a tirzepatide-based protocol that includes added ingredients and services. If your priority is sticker price alone, Maximus is lower priced according to the supplied facts.
See Maximus pricing and telemedicine flow
Support, monitoring, and program design
HumeCare+ sells a bundled protocol not just a prescription. The company pairs physician-prescribed compounded GLP-1 medication with glycine, vitamins B6 and B12, a dedicated app, continuous physician optimization, and monthly body composition scans. HumeCare+ positions these elements to address muscle loss and side effects that it says bare GLP-1 programs ignore. Maximus offers a simple telemedicine pathway: prescriptions approved by licensed doctors and filled through trusted U.S. pharmacies with convenient online access. Maximus publishes less detail about supportive ingredients and monitoring beyond medication delivery and telemedicine visits.
Learn about HumeCare+ monitoring and app
Safety, compounded medications, and transparency
Both providers use compounded medications. HumeCare+ explicitly notes that compounded medications are not FDA-evaluated for safety, quality, or efficacy. Maximus includes a regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. HumeCare+ also calls out that GLP-1 drugs carry serious risks including a boxed warning for thyroid C cell tumors. Neither provider should be assumed to represent branded, FDA-approved finished products unless the provider states otherwise.
HumeCare+ vs Maximus: which to pick
Choose HumeCare+ if you want a bundled program that adds glycine and B vitamins to a compounded GLP-1 formula, monthly body composition scans to track lean mass, 24/7 clinician access, and a published 10% or your money back promise over six months. Choose Maximus if your priority is the lowest listed monthly price and a straightforward telemedicine route to compounded semaglutide prescribed by licensed doctors and fulfilled through U.S. pharmacies.
Start Maximus telemedicine signup
Compare HumeCare+ plans and terms
To recap, HumeCare+ vs Maximus presents a tradeoff between a protocol with added supportive therapies, scans, and a money back promise at higher monthly cost and a lower base price semaglutide telemedicine option with licensed prescribers and U.S. pharmacy fulfillment. Use the facts above to match your priorities to the provider that fits best.